Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel partial amides of CLODRONIC ACID (cas 10596-23-3)

Add time:08/18/2019    Source:sciencedirect.com

Novel partial amides of clodronic acid were synthesized and evaluated in vitro for their properties as bioreversible prodrugs of clodronate. The hydrolysis studies indicated that these derivatives release the parent drug via chemical hydrolysis. Monoamides were hydrolysed rapidly (t1/2=16–19 min at pH 7.4) to clodronic acid, which suggests that they are useful intermediates in the design of enzymatically labile double prodrugs of clodronate.

We also recommend Trading Suppliers and Manufacturers of CLODRONIC ACID (cas 10596-23-3). Pls Click Website Link as below: cas 10596-23-3 suppliers

Prev:ArticlesEffects of zoledronic acid versus CLODRONIC ACID (cas 10596-23-3) on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Next:X-ray diffraction study of polymeric Mg complexes of CLODRONIC ACID (cas 10596-23-3))